Table 1.

Summary of pharmacological studies for Garcinia indica.

Pharmacological Activity	Tested Substance	In Vitro/ In Vivo	Model	Dose/Concentration	Ref.
Antioxidant	Aqueous extract	In vivo	Wister albino rats	400 and 800 mg/kg	[36]
	Fruit extract	In vitro	-	1.5 mM	[37]
	Garcinol-enriched fraction	In vivo	C57BL/6 male mice	25, 50, and 100 mg/kg	[38]
	Aqueous extract	In vitro	-	-	[39]
		In vivo	Wister albino rats	250 and 500 mg/kg
	G. indica fruit rind powder	In vivo	Swiss albino mice, Wister rats	0.5, 1, and 2% w/w	[40]
Anti-obesity	Garcinol-enriched fraction	In vivo	C57BL/6 male mice	25, 50, and 100 mg/kg	[38]
	Fruit extract	In vitro	3T3-L1 preadipocytes	1 and 2 µg/mL	[41]
		In vivo	C57BL/6 male mice	0.01% w/w
Anti-arthritic	Garcinol-enriched fraction	In vivo	Male Wistar rats	10 mg/kg	[42]
Anti-inflammatory	Garcinol-enriched fraction	In vivo	C57BL/6 male mice	25, 50, and 100 mg/kg	[38]
Antidepressant and anxiolytic effect	G. indica fruit rind powder	In vivo	Swiss albino mice, Wister rats	0.5, 1, and 2%	[40]
Antibacterial	Fruit extract	In vitro	-	1.5 mM	[37]
Hepatoprotective	Aqueous extract	In vivo	Wister albino rats	400 and 800 mg/kg	[36]
Cardioprotective	Garcinol-enriched fraction	In vivo	C57BL/6 male mice	25, 50, and 100 mg/kg	[38]
	Aqueous extract	In vivo	Wister albino rats	250 and 500 mg/kg	[39]